Category Archives: India
By Shalini Bhutani, The Economic & Political Weekly (Vol. 52 Issue No. 7) With other mega regional trade agreements like the Trans–Pacific Partnership in uncertainty, trade treaties like the Regional Comprehensive Economic Partnership will acquire greater significance beyond their original … Continue reading
The tug of war continues. Even as the Indian Pharmaceutical Alliance, the domestic drug industry lobby group, has appealed to the US Trade Representative to remove India from its Priority Watch List – the latter includes countries that are alleged … Continue reading
The Indian Patent Office recently denied a patent for the drug Xtandi (Enzalutamide) by Japanese firm Astellas Pharma used in treatment of prostate cancer. This decision comes in the light of the pre-grant opposition filed by pharma companies BDR Pharma, drug … Continue reading
In the recently concluded US India Trade Policy Forum meeting held in Delhi, both countries laid emphasis on the importance of having a robust and balanced IPR protection in fostering creativity, promoting innovation, and attracting investment. Indian government was praised … Continue reading
Source: Deccan Herald | August 30, 2016 The US on Monday prodded India to do “a lot more” to strengthen the Intellectual Property Rights regime to help not only the foreign investors, but also domestic innovators.